B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability
Open accessAbstract
Here we report inherited dysregulation of protein phosphatase activity as a cause of intellectual disability (ID). De novo missense mutations in 2 subunits of serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) were identified in 16 individuals with mild to severe ID, long-lasting hypotonia, epileptic susceptibility, frontal bossing, mild hypertelorism, and downslanting palpebral fissures. PP2A comprises catalytic (C), scaffolding (A), and regulatory (B) subunits that determine subcellular anchoring, substrate specificity, and physiological function. Ten patients had mutations within a highly conserved acidic loop of the PPP2R5D-encoded B56δ regulatory subunit, with the same E198K mutation present in 6 individuals. Five patients had mutations in the PPP2R1A-encoded scaffolding Aα subunit, with the same R182W mutation in 3 individuals. Some Aα cases presented with large ventricles, causing macrocephaly and hydrocephalus suspicion, and all cases exhibited partial or complete corpus callosum agenesis. Functional evaluation revealed that mutant A and B subunits were stable and uncoupled from phosphatase activity. Mutant B56δ was A and C binding-deficient, while mutant Aα subunits bound B56δ well but were unable to bind C or bound a catalytically impaired C, suggesting a dominant-negative effect where mutant subunits hinder dephosphorylation of B56δ-anchored substrates. Moreover, mutant subunit overexpression resulted in hyperphosphorylation of GSK3β, a B56δ-regulated substrate. This effect was in line with clinical observations, supporting a correlation between the ID degree and biochemical disturbance.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dysregulation of PP2A is strongly associated with several diseases, including Alzheimer's disease, intellectual disability, autoimmune disease, diabetes and diverse cancers.
“Thus, it is not surprising that dysregulation of PP2A has been strongly associated with several disease states, including Alzheimer's disease, intellectual disability (ID), autoimmune disease, diabetes and diverse cancers [1][2][3][4][5].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 47 · Cited by 124
Research works printed but not linked: 1
- Chen W, Arroyo JD, Timmons JC, Posse- mato R, Hahn WC. Cancer-associated PP2A Aalpha subunits induce functional haploin- sufficiency and tumorigenicity. Cancer Res. 2005;65(18):8183-8192.
- Authors
- Houge, G., Haesen, D., Vissers, L. E. L. M., Mehta, S., Parker, M. J., Wright, M., Vogt, J., McKee, S., Tolmie, J. L., Cordeiro, N., Kleefstra, T., Willemsen, M. H., Reijnders, M. R. F., Berland, S., Hayman, E., Lahat, E., Brilstra, E. H., van Gassen, K. L. I., Zonneveld-Huijssoon, E., de Bie, C. I., Hoischen, A., Eichler, E. E., Holdhus, R., Steen, V. M., Døskeland, S. O., Hurles, M. E., FitzPatrick, D. R., study, T. D. D. D. (., & Janssens, V.
- Affiliations
- Haukeland University Hospital (NO)
- KU Leuven (BE)
- Radboud University Nijmegen (NL)
- Addenbrooke's Hospital (GB)
- Sheffield Children's Hospital (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Birmingham Women's Hospital (GB)
- Belfast City Hospital (GB)
- NHS Greater Glasgow and Clyde (GB)
- NHS Ayrshire and Arran (GB)
- Assaf Harofeh Medical Center (IL)
- University Medical Center Utrecht (NL)
- University of Washington (US)
- University of Bergen (NO)
- Wellcome Sanger Institute (GB)
- Institute of Genetics and Cancer (GB)
- Corresponding author
- Houge, Gunnar
- Haesen, Dorien
- the Deciphering Developmental Disorders (DDD) study
- ORCID
- Houge, Gunnar
- Vissers, Lisenka E.L.M.
- Mehta, Sarju
- Parker, Michael J.
- Vogt, Julie
- McKee, Shane
- Cordeiro, Nuno
- Kleefstra, Tjitske
- Willemsen, Marjolein H.
- Reijnders, Margot R.F.
- Berland, Siren
- Brilstra, Eva H.
- Hoischen, Alexander
- Eichler, Evan E.
- Steen, Vidar M.
- Døskeland, Stein Ove
- Hurles, Matthew E.
- FitzPatrick, David R.
- Janssens, Veerle
- Venue
- Journal of Clinical Investigation
- Published
- 2015-07-13
- Volume
- 125
- Issue
- 8
- Pages
- 3051-3062
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4623570
- OpenAlex
- W2102290245
- Cited by
- 124
- References
- 47
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 16 · 2023: 15 · 2022: 15 · 2021: 13 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 6 · 2016: 8 · 2015: 1
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Wellcome Trust (WT 098051)
- Australian Government
- National Institute for Health and Care Research
- ZonMw
- Belgian Federal Science Policy Office (P7/13)
- Fonds Wetenschappelijk Onderzoek (P7/13)
- KU Leuven (P7/13)
- Helse Vest
- Vlaamse regering
- National Institutes of Health
- National Institute of Mental Health (R01MH101221)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- intellectual disability, protein phosphatase 2A, PPP2R5D, PPP2R1A, de novo missense variant, dominant negative effect, agenesis of the corpus callosum, hydrocephalus, macrocephaly, hypotonia, frontal bossing, hypertelorism
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Adolescent, Adult, Mental Disorders, Child, Child, Preschool, Corpus Callosum, Female, Humans, Infant, Male, Middle Aged, Phosphorylation, Protein Structure, Secondary, Protein Structure, Tertiary, Amino Acid Substitution, Mutation, Missense, Glycogen Synthase Kinase 3, Protein Phosphatase 2, Agenesis of Corpus Callosum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review